Form 4: Centessa Pharmaceuticals CEO Saurabh Saha Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Centessa Pharmaceuticals CEO Saurabh Saha sold a portion of his ordinary shares between October 21 and October 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Saurabh Saha, CEO of Centessa Pharmaceuticals plc, reported the sale of ordinary shares between October 21 and October 23, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 16, 2024.
- On October 21, 2024, 22,205 shares were sold at a weighted average price of $15.801.
- On October 22, 2024, 30,203 shares were sold at a weighted average price of $15.6663.
- On October 23, 2024, 2,592 shares were sold at a weighted average price of $15.3151.
- Following these transactions, Saha directly owns 630,661 ordinary shares and indirectly owns 38,000 shares through a trust.
- The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price within the specified ranges upon request.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting share sales by the CEO under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
Share sales by company executives are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares at predetermined times and prices, avoiding accusations of trading on non-public information. Investors often monitor these transactions for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- Shareholders may be interested in the CEO's transactions, but the sales are under a pre-arranged plan.
Key Dates
| Date | Description |
|---|---|
| May 16, 2024 | Date of adoption of Rule 10b5-1 trading plan |
| October 21, 2024 | Date of first reported transaction |
| October 22, 2024 | Date of second reported transaction |
| October 23, 2024 | Date of third reported transaction and filing date of Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.